Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Chiang, Chia Hung ^a,b   Huang, Po Hsun ^a,b   Chung, Fa Po ^a,b   Chen, Zu Yin ^a,b   Leu, Hsin Bang ^a,b   Huang, Chin Chou ^a,b   Wu, Tao Cheng ^a,b   Chen, Jaw Wen ^a,b   Lin, Shing Jong ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; GLUCOSE; TRIACYLGLYCEROL; VASCULOTROPIN RECEPTOR 2;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL ADHESION; CELL FUNCTION; CELL LEVEL; CELL MIGRATION; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERURICEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ATHEROSCLEROSIS; BLOOD; BLOOD CELL; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CELL COUNT; ENDOTHELIUM CELL; FATTY LIVER; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STEM CELL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD CELLS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CELL COUNT; ENDOTHELIAL CELLS; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STEM CELLS;

EID: 84862279461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031799     Document Type: Article

References (43)

1. Adams LA, Angulo P, (2005) Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22 (9): 1129-1133.
2. Lonardo A, Bellini M, Tartoni P, Tondelli E, (1997) The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern. Ital J Gastroenterol Hepatol 29 (4): 351-356.
3. el-Hassan AY, Ibrahim EM, al-Mulhim FA, Nabhan AA, Chammas MY, (1992) Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management. Br J Radiol 65 (777): 774-778.
4. Fan JG, Zhu J, Li XJ, Li L, Dai F, et al. (2005) Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 43 (3): 508-514.
5. Tarantino G, Saldalamacchia G, Conca P, Arena A, (2007) Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 22 (3): 293-303.
6. Kotronen A, Yki-Jarvinen H, (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28 (1): 27-38.
7. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, et al. (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28 (6): 1039-1049.
8. Chiang CH, Huang CC, Chan WL, Chen JW, Leu HB, (2010) The severity of non-alcoholic fatty liver disease correlates with high sensitivity C-reactive protein value and is independently associated with increased cardiovascular risk in healthy population. Clin Biochem 43 (18): 1399-1404.
9. Sung KC, Ryan MC, Wilson AM, (2009) The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 203 (2): 581-586.
10. Bonetti PO, Lerman LO, Lerman A, (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23 (2): 168-175.
11. Verhaar MC, Rabelink TJ, (1998) Endothelial function: strategies for early intervention. Cardiovasc Drugs Ther 12 (Suppl 1): 125-134.
12. Werner N, Priller J, Laufs U, Endres M, Bohm M, et al. (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22 (10): 1567-1572.
13. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (7): 593-600.
14. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (1): E1-7.
15. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, (2004) Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107 (3): 273-280.
16. Jialal I, Devaraj S, Singh U, Huet BA, (2010) Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis 211 (1): 297-302.
17. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (10): 999-1007.
18. Senturk O, Kocaman O, Hulagu S, Sahin T, Aygun C, et al. (2008) Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J 38 (3): 183-189.
19. Vlachopoulos C, Manesis E, Baou K, Papatheodoridis G, Koskinas J, et al. (2010) Increased arterial stiffness and impaired endothelial function in nonalcoholic Fatty liver disease: a pilot study. Am J Hypertens 23 (11): 1183-1189.
20. Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, et al. (2009) Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 32 (1): 147-152.
21. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (3): 433-438.
22. Huang PH, Lu TM, Wu TC, Lin FY, Chen YH, et al. (2008) Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. Coron Artery Dis 19 (3): 187-193.
23. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30 (4): 869-877.
24. Huang PH, Huang SS, Chen YH, Lin CP, Chiang KH, et al. (2010) Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J Hypertens 28 (8): 1655-1665.
25. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, et al. (2008) Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 197 (2): 496-503.
26. Huang PH, Chen YH, Chen YL, Wu TC, Chen JW, et al. (2007) Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Heart 93 (9): 1064-1070.
27. Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, et al. (2003) Prognosis of patients with a diagnosis of fatty liver-a registry-based cohort study. Hepatogastroenterology 50 (54): 2101-2104.
28. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, et al. (2009) Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 7 (2): 234-238.
29. Lin YC, Lo HM, Chen JD, (2005) Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol 11 (31): 4838-4842.
30. Mirbagheri SA, Rashidi A, Abdi S, Saedi D, et al. (2007) Liver: an alarm for the heart? Liver Int 27 (7): 891-894.
31. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, et al. (2005) Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 25 (5): 1045-1050.
32. Fuster V, Badimon L, Badimon JJ, Chesebro JH, (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 (5): 310-318.
33. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, et al. (2003) Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (4): 457-463.
34. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, et al. (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42 (2): 473-480.
35. Targher G, Day CP, Bonora E, (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363 (14): 1341-1350.
36. Feldstein AE, (2010) Novel insights into the pathophysiology of nonalcoholic fatty liver disease. Semin Liver Dis 30 (4): 391-401.
37. Miller-Kasprzak E, Bogdanski P, Pupek-Musialik D, Jagodzinski PP, (2011) Insulin resistance and oxidative stress influence colony-forming unit-endothelial cells capacity in obese patients. Obesity (Silver Spring) 19 (4): 736-742.
38. Pessayre D, Fromenty B, (2005) NASH: a mitochondrial disease. J Hepatol 42 (6): 928-940.
39. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, et al. (2005) Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 41 (5): 1074-1084.
40. Drexler H, Hornig B, (1993) Endothelial dysfunction in human disease. J Mol Cell Cardiol 31 (1): 51-60.
41. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, et al. (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40 (1): 46-54.
42. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, et al. (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109 (17): 2058-2067.
43. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, et al. (2006) Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37 (9): 2277-2282.